William Sheremata

4.8k total citations · 1 hit paper
68 papers, 3.5k citations indexed

About

William Sheremata is a scholar working on Immunology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, William Sheremata has authored 68 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 28 papers in Pathology and Forensic Medicine and 20 papers in Neurology. Recurrent topics in William Sheremata's work include Multiple Sclerosis Research Studies (23 papers), T-cell and Retrovirus Studies (14 papers) and Peripheral Neuropathies and Disorders (13 papers). William Sheremata is often cited by papers focused on Multiple Sclerosis Research Studies (23 papers), T-cell and Retrovirus Studies (14 papers) and Peripheral Neuropathies and Disorders (13 papers). William Sheremata collaborates with scholars based in United States, Canada and United Kingdom. William Sheremata's co-authors include Alireza Minagar, Michele Libonati, Catherine M. Dalton, Paul O’Connor, George P. Rice, Katherine Miszkiel, Omar Khan, David H. Miller, Lance D. Blumhardt and Yeon S. Ahn and has published in prestigious journals such as Nature, New England Journal of Medicine and Neurology.

In The Last Decade

William Sheremata

68 papers receiving 3.3k citations

Hit Papers

A Controlled Trial of Natalizumab for Relapsing Multiple ... 2003 2026 2010 2018 2003 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
    2003 936 citations William Sheremata et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Sheremata United States 31 1.4k 1.3k 810 649 624 68 3.5k
Dale E. McFarlin United States 34 1.8k 1.2× 3.2k 2.4× 583 0.7× 712 1.1× 1.0k 1.6× 84 5.6k
Takahiko Saida Japan 32 971 0.7× 623 0.5× 1.9k 2.4× 214 0.3× 591 0.9× 130 3.7k
Ute Traugott United States 31 1.1k 0.8× 1.5k 1.1× 326 0.4× 383 0.6× 601 1.0× 70 3.0k
D. E. McFarlin United States 34 1.3k 0.9× 3.0k 2.2× 374 0.5× 720 1.1× 1.3k 2.0× 79 5.1k
H. Link Sweden 26 1.0k 0.7× 779 0.6× 1.0k 1.2× 310 0.5× 549 0.9× 59 3.0k
Jan Lycke Sweden 43 4.1k 2.8× 1.1k 0.8× 1.8k 2.3× 1.3k 2.0× 1.1k 1.8× 148 6.3k
M. C. Dal Canto United States 29 552 0.4× 1.1k 0.8× 730 0.9× 253 0.4× 650 1.0× 53 3.1k
DL Longo United States 37 1.1k 0.8× 2.2k 1.7× 211 0.3× 1.6k 2.5× 988 1.6× 83 4.8k
Naganari Ohkura Japan 37 171 0.1× 4.0k 2.9× 220 0.3× 1.1k 1.7× 1.5k 2.4× 85 6.1k
Masaaki Niino Japan 30 1.7k 1.2× 1.3k 1.0× 623 0.8× 426 0.7× 661 1.1× 140 3.3k

Countries citing papers authored by William Sheremata

Since Specialization
Citations

This map shows the geographic impact of William Sheremata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Sheremata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Sheremata more than expected).

Fields of papers citing papers by William Sheremata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Sheremata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Sheremata. The network helps show where William Sheremata may publish in the future.

Co-authorship network of co-authors of William Sheremata

This figure shows the co-authorship network connecting the top 25 collaborators of William Sheremata. A scholar is included among the top collaborators of William Sheremata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Sheremata. William Sheremata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perzova, Raisa, Patricia Benz, Lynn Abbott, et al.. (2014). Increased Seroreactivity to Human T Cell Lymphoma/Leukemia Virus-Related Endogenous Sequence-1 Gag Peptides in Patients with Human T Cell Lymphoma/Leukemia Virus Myelopathy. AIDS Research and Human Retroviruses. 31(2). 242–249. 5 indexed citations
2.
Sheremata, William, et al.. (2014). Multiple Sclerosis and the Cerebellum. Neurologic Clinics. 32(4). 957–977. 16 indexed citations
3.
Sheremata, William, Andrew Brown, & Kottil Rammohan. (2014). Dimethyl fumarate for treating relapsing multiple sclerosis. Expert Opinion on Drug Safety. 14(1). 161–170. 28 indexed citations
4.
Perzova, Raisa, Patricia Benz, Lynn Abbott, et al.. (2013). Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy. Virology Journal. 10(1). 360–360. 14 indexed citations
5.
Thomas, Anish, Raisa Perzova, Lynn Abbott, et al.. (2010). LGL Leukemia and HTLV. AIDS Research and Human Retroviruses. 26(1). 33–40. 22 indexed citations
6.
Sheremata, William, Wenche Jy, Lawrence L. Horstman, et al.. (2008). Evidence of platelet activation in multiple sclerosis. Journal of Neuroinflammation. 5(1). 27–27. 139 indexed citations
7.
Sheremata, William, et al.. (2006). Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis.. Journal of Neuroinflammation. 3(1). 23–23. 49 indexed citations
8.
Sheremata, William, et al.. (2006). The role of CD4+ T-cells in the development of MS. Neurological Research. 28(3). 245–249. 17 indexed citations
9.
Minagar, Alireza, William Sheremata, & William J. Weiner. (2002). Transient movement disorders and multiple sclerosis. Parkinsonism & Related Disorders. 9(2). 111–113. 15 indexed citations
10.
Lowis, George W., et al.. (1998). HTLV-II Risk Factors in Native Americans in Florida. Neuroepidemiology. 18(1). 37–47. 10 indexed citations
11.
Elgart, George W., William Sheremata, & Yeon S. Ahn. (1997). Cutaneous reactions to recombinant human interferon beta-1b: The clinical and histologic spectrum. Journal of the American Academy of Dermatology. 37(4). 553–558. 47 indexed citations
12.
Sheremata, William, William J. Harrington, Steven K. H. Foung, et al.. (1993). Association of ‘(tropical) ataxic neuropathy’ with HTLV-II. Virus Research. 29(1). 71–77. 40 indexed citations
13.
Sheremata, William. (1992). Human T Lymphotropic Virus Type I—Associated Myelopathy. Archives of Neurology. 49(11). 1113–1113. 15 indexed citations
14.
Harrington, William J., et al.. (1991). Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM): Treatment with an Anabolic Steroid Danazol. AIDS Research and Human Retroviruses. 7(12). 1031–1034. 50 indexed citations
15.
Telischi, Fred F., et al.. (1991). Hemifacial Spasm: Occurrence in Multiple Sclerosis. Archives of Otolaryngology - Head and Neck Surgery. 117(5). 554–556. 20 indexed citations
16.
Berger, Joseph R., William Sheremata, Lionel Resnick, et al.. (1989). Multiple sclerosis‐like illness occurring with human immunodeficiency virus infection. Neurology. 39(3). 324–324. 89 indexed citations
17.
Post, M. Judith Donovan, Larry G. Tate, Robert M. Quencer, et al.. (1988). CT, MR, and Pathology in HIV Encephalitis and Meningitis. American Journal of Neuroradiology. 9(3). 469–476. 9 indexed citations
18.
Jacobson, Steven, Vladimir Zaninovic, Carlos A. Mora, et al.. (1988). Immunological findings in neurological diseases associated with antibodies to HTLV-I: Activated lymphocytes in tropical spastic paraparesis. Annals of Neurology. 23(S1). S196–S200. 116 indexed citations
19.
DeFreitas, E, Zofia Wróblewska, Gerd G. Maul, et al.. (1987). HTLV-I Infection of Cerebrospinal Fluid T Cells from Patients with Chronic Neurologic Disease. AIDS Research and Human Retroviruses. 3(1). 19–32. 22 indexed citations
20.
Sheldon, Jerome J., et al.. (1985). MR Imaging of Multiple Sclerosis: Comparison with Clinical and CT Examinations in 74 Patients. American Journal of Neuroradiology. 6(5). 683–690. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale E. McFarlin Breakdown of academic impact, for papers by Takahiko Saida Breakdown of academic impact, for papers by Ute Traugott Breakdown of academic impact, for papers by D. E. McFarlin Breakdown of academic impact, for papers by H. Link Breakdown of academic impact, for papers by Jan Lycke Breakdown of academic impact, for papers by M. C. Dal Canto Breakdown of academic impact, for papers by DL Longo Breakdown of academic impact, for papers by Naganari Ohkura Breakdown of academic impact, for papers by Masaaki Niino
Rankless by CCL
2026